- A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature. 2012 Academic Article GET IT
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nature Medicine. 2008 Academic Article GET IT
High-resolution genomic profiles of human lung cancer.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 283